INDUSTRY EXPERT ARTICLES

‘Closing the Loop: Why a Test Alone isn’t enough’ is about how diagnostics is the gateway to precision Medicine. But what happens before and after the test? In a healthcare system made up of multiple initiatives and institutions, working in siloes, even the most advanced insights can fail to reach their potential.

This article includes a Real-World Example: At-Home Cardiovascular Risk Screening. Take cardiovascular disease a leading cause of death in both the US and UK. In traditional systems, screening often relies on in-person visits that many people never make, particularly amongst the most socially deprived groups.

Rethinking an Overlooked Corner of GI Care / Where Innovation Stalled and Why It Matters

Imagine what modern medicine would be like without the ability to effectively and consistently administer drugs intravenously. That’s a good way to frame the huge delivery limitation that plagues neuroscience: Despite all the advances in drug discovery over the past decades, the biggest roadblock to treating brain cancers and other neurological diseases and disorders remains the brain’s own protective shield, the blood-brain barrier. Read on.

While the impact of tariffs is currently the question at the forefront of healthcare executives’ minds, health systems can take proactive steps to protect themselves from supply chain disruptions of all sorts—including material shortages, labor strikes, or public health emergencies. Any of these scenarios could lead health systems to face higher costs and delayed access to supplies and parts, which can impact hospital efficiency and patient care.

Discover how at-home diagnostics are transforming the detection of undiagnosed sleep apnea and enabling essential treatments.